Canaccord Genuity Wealth Limited and OCTOPUS INVESTMENTS LTD separately disclosed interests in Advanced Medical Solutions Group PLC under Rule 8.3 of the Takeover Code. In a disclosure dated 3 September 2026, Canaccord reported 9,356,517 5p ordinary shares, representing 4.2375%, as of 2 September, after previously reporting 9,383,857 shares, or 4.2498%, as of 28 August. The later filing recorded sales of 2,320 shares at 280.5599 pence and 4,920 at 281.08 pence. Octopus previously reported 15,953,578 shares, or 7.23%, alongside sales and an in-specie transfer of 350 shares. Both firms reported no derivatives, subscription rights, short positions, or related dealing arrangements.